Why the study?
Does Mouse Norovirus infection reduce MHC class I surface expression and inhibit CD8+ T cell activation?
Does Mouse Norovirus infection reduce MHC class I surface expression and inhibit CD8+ T cell activation?
Mouse norovirus evades host immune responses by downregulating MHC class I surface expression, impairing CD8+ T cell recognition and activation.
May inform norovirus antiviral strategies; leaves open whether MHC I restoration enhances CD8+ T cell immunity in patients.
Human noroviruses (HuNoVs) are the major cause of nonbacterial gastroenteritis worldwide and impose a great burden on patients and health systems every year. So far, no antiviral treatment or vaccine is available. We show that MNV evades the host immune response by reducing the amount of MHC class I proteins displayed on the cell surface. This reduction leads to a decrease in viral antigen presentation and interferes with the CD8 + T cell response. CD8 + T cells respond to foreign antigen by activating cytotoxic pathways and inducing immune memory to the infection. By evading this immune response, MNV is able to replicate efficiently in the host, and the ability of cells to respond to consecutive infections is impaired. These findings have a major impact on our understanding of the ways in which noroviruses interact with the host immune response and manipulate immune memory.
No takes yet. Share an insight, caveat, or question.
Fritzlar et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: